Author

Levon Halabelian

Institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre, Structural Genomics Consortium

Observed institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre, Structural Genomics Consortium

OpenAlex ID: A5126861481

IMPECCABLE: A Digital Twin Drug Discovery Workflow Comprising AI, Physics and Experiment & the Creation of Nanomolar-Potent Inhibitors

2026 · Wei Jiang, Agastya P Bhati, et al. · ChemRxiv

Chemically induced USP21-KLHL12 association recruits USP21 to COPII assembly

2026 · Victoria Vu, Michael Kanaris, et al. · bioRxiv (Cold Spring Harbor Laboratory)

CACHE Challenge #4: Targeting the TKB Domain of the E3 ligase CBLB, an Immuno-Oncology Target

2026 · Madhushika Silva, Oleksandra Herasymenko, et al. · ChemRxiv

Identification and optimization of first-in-class RNA helicase inhibitors of DDX1, LGP2, and MDA5

2026 · Xiaowen Wang, Feijun Wang, et al. · European Journal of Medicinal Chemistry

The Emory‐Sage‐SGC‐JAX TREAT‐AD Center: Developing Resources for Alzheimer’s Disease Novel Targets

2025 · Karina Leal, Elizabeth L Zoeller, et al. · Alzheimer s & Dementia

Works count: 5

Citation count:

H-index:

I10-index: